Clinical Trials Directory

Trials / Conditions / Undifferentiated Ovarian Carcinoma

Undifferentiated Ovarian Carcinoma

15 registered clinical trials studyying Undifferentiated Ovarian Carcinoma.

StatusTrialSponsorPhase
CompletedPembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube,
NCT02853318
Roswell Park Cancer InstitutePhase 2
CompletedEverolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube
NCT02283658
Mayo ClinicPhase 2
CompletedVaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavi
NCT02111941
Mayo ClinicEARLY_Phase 1
UnknownDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo
NCT00719303
Gynecologic Oncology GroupPhase 3
CompletedPegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients Wi
NCT01459380
National Cancer Institute (NCI)Phase 1
TerminatedGranisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap
NCT01275664
Gynecologic Oncology GroupN/A
CompletedTLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients Wit
NCT01294293
Gynecologic Oncology GroupPhase 1
CompletedIntraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelia
NCT01074411
National Cancer Institute (NCI)Phase 1
CompletedChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone
NCT01080521
Gynecologic Oncology Group—
CompletedA6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
NCT00939809
Gynecologic Oncology GroupPhase 2
CompletedCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithe
NCT00814086
Gynecologic Oncology GroupPhase 1
TerminatedYKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal
NCT00899093
Gynecologic Oncology Group—
CompletedCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian
NCT00262847
National Cancer Institute (NCI)Phase 3
CompletedPolyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopia
NCT00060359
Gynecologic Oncology GroupPhase 1
TerminatedCombination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian
NCT00004221
Gynecologic Oncology GroupPhase 2